← Human Trials & Peer-Reviewed Studies

Vitamin D-fortified liquid milk: benefits for the elderly community-based population.

Plain-language guide to PMID 9504953 (1998): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 23 subjects.

Key Facts

PMID
9504953
Journal
Calcified tissue international
Year
1998
Study type
Randomized Controlled Trial
Authors
Keane EM et al. (5 authors)
DOI
10.1007/s002239900435

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Each subject had a dietary assessment, mental test score, outdoor score, serum 25 hydroxyvitamin D level, and a general biochemical screening at baseline in April 1993 which was repeated in September 1993, April 1994, and September 1994.

Who Took Part

According to the abstract, 23 subjects were involved.

By PubMed's age tags, the people studied were older adults and people over 80, both men and women.

How the Study Was Run

The researchers set it up as a randomized and double-blind study.

The subjects were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

What Was Measured

Each subject had a dietary assessment, mental test score, outdoor score, serum 25 hydroxyvitamin D level, and a general biochemical screening at baseline in April 1993 which was repeated in September 1993, April 1994, and September 1994.

The subject headings attached to it are Aging, Calcium, Community Health Services, Food, Fortified, Health Services for the Aged, Milk and Vitamin D.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 23 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1998 (Calcified tissue international), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.